Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

BACKGROUND: Checkpoint inhibitor-related pneumonitis (CIP) is a potentially fatal immune-related adverse event that occurs during treatment with immune checkpoint inhibitors (ICIs). However, the roles played by peripheral blood parameters in CIP development remain unclear. Here, we aimed to identify...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Front Oncol
المؤلفون الرئيسيون: Lin, Xinqing, Deng, Haiyi, Yang, Yilin, Wu, Jianhui, Qiu, Guihuan, Li, Suyang, Xie, Xiaohong, Liu, Ming, Xie, Zhanhong, Qin, Yinyin, Song, Yong, Zhou, Chengzhi
التنسيق: Artigo
اللغة:Inglês
منشور في: Frontiers Media S.A. 2021
الموضوعات:
Oncology
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313853/
https://ncbi.nlm.nih.gov/pubmed/34327140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.698832
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة